CNBS

Amplify Seymour Cannabis ETF [CNBS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CNBS Stock Summary

Top 10 Correlated ETFs

CNBS


Top 10 Correlated Stocks

CNBS


In the News

05:41 28 Mar 2024 CNBS

ETF Themes That Dominated in Q1 2023

As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipients of investor flows this year.

09:36 28 Mar 2024 CNBS

Is Rescheduling a Certainty for Cannabis? ETFs That Surge

In a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana, criticizing its current Schedule 1 classification as "absurd" and "patently unfair." She put stress on the need for swift action and highlighted ongoing efforts toward rescheduling.

11:01 28 Mar 2024 CNBS

Cannabis ETFs Jump on Imminent Rescheduling News

Cannabis stocks & ETFs jumped on Mar 15 after a prominent hedge fund manager suggested that regulators will soon reclassify marijuana as a less dangerous drug.

09:31 28 Mar 2024 CNBS

Disruptive Tech Theme of the Week: Top Thematic ETF Flows 2023

To close out the year, I thought it would be interesting to see which thematic categories experienced the most inflows in 2023, demonstrating proverbially “where the puck was going.” This data, sourced from Bloomberg and VettaFi's internal data, is interesting because it does not necessarily align with performance.

07:30 28 Mar 2024 CNBS

Watchlist Alert: Best Cannabis ETFs for the Final Quarter of 2023

The cannabis sector continues to entice investors with its prospects for expansion and financial success as we take on the last quarter of 2023. Cannabis Exchange-Traded Funds (ETFs) have become popular for investors seeking exposure to this dynamic sector while keeping a diversified portfolio. The best Cannabis ETFs to watch in 2023's fourth quarter will be examined in this piece, along with their dividend yields and suitability for both long- and short-term trading approaches.

10:00 28 Mar 2024 CNBS

Reasons To Be Cautiously Optimistic About Cannabis

Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, timeframes, and political catalysts when choosing cannabis companies to invest in.

12:31 28 Mar 2024 CNBS

Marijuana ETFs Rise – and Fall – on Regulatory Hopes

Like any recovering reporter, I like to keep tabs on my old beats, and the marijuana ETF space never disappoints. Or, perhaps more accurately, it never stops disappointing.

07:30 28 Mar 2024 CNBS

Marijuana Watchlist: September 2023's Standout ETFs in Cannabis

In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory landscapes evolve and societal attitudes toward marijuana become more accepting, the market for cannabis-related products expands at an unprecedented rate.

02:17 28 Mar 2024 CNBS

Behind the Recent Surge in Marijuana ETFs

In a significant development, the Department of Health and Human Services (HHS) has recently initiated a review of marijuana's classification under the Controlled Substances Act.

01:51 28 Mar 2024 CNBS

Top Performing ETFs: Cannabis ETFs Lead

This week, cannabis ETFs took the top performing ETF positions, according to Logicly. Eight of the top twelve strategies, including the top three, all focus on cannabis.

CNBS Financial details

Company Rating
-
Market Cap
31.49M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
8.37%
SMA50
16.19%
SMA100
44.69%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
5.82M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
3.38-5.98
52W High
+17.8%
52W Low
+96.33%
RSI
70.32
Rel Volume
0.72
Avg Volume
35.04K
Volume
25.31K
Perf Week
13.05%
Perf Month
25.32%
Perf Quarter
32.06%
Perf Half Y
19.36%
-
-
-
-
Beta
1.4
-
-
Volatility
0.25%, 0.35%
Prev Close
7.29%
Price
5.89
Change
10.09%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap